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Abstract
Objectives: Selectively reported results from only well‐performing cutoffs in diag-
nostic accuracy studies may bias estimates in meta‐analyses. We investigated cutoff
reporting patterns for the Patient Health Questionnaire‐9 (PHQ‐9; standard cutoff
10) and Edinburgh Postnatal Depression Scale (EPDS; no standard cutoff, commonly
used 10–13) and compared accuracy estimates based on published cutoffs versus all
cutoffs.
Methods: We conducted bivariate random effects meta‐analyses using individual
participant data to compare accuracy from published versus all cutoffs.
Results: For the PHQ‐9 (30 studies, N = 11,773), published results underestimated
sensitivity for cutoffs below 10 (median difference: −0.06) and overestimated for
cutoffs above 10 (median difference: 0.07). EPDS (19 studies, N = 3637) sensitivity
estimates from published results were similar for cutoffs below 10 (median differ-
ence: 0.00) but higher for cutoffs above 13 (median difference: 0.14). Specificity
estimates from published and all cutoffs were similar for both tools. The mean cutoff
of all reported cutoffs in PHQ‐9 studies with optimal cutoff below 10 was 8.8
compared to 11.8 for those with optimal cutoffs above 10. Mean for EPDS studies
with optimal cutoffs below 10 was 9.9 compared to 11.8 for those with optimal
cutoffs greater than 10.
Conclusion: Selective cutoff reporting was more pronounced for the PHQ‐9 than
EPDS.
K E YWORD S
diagnostic test accuracy, individual participant data meta‐analysis, meta‐analysis, publication
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1 | INTRODUCTION
Selective reporting occurs when authors make decisions regarding
publication of study results based on whether or not outcomes are
favorable (Kirkham et al., 2010). In accuracy studies of ordinal or
continuous tests, selective cutoff reporting occurs when results are
published for one or more cutoffs that maximize sensitivity and
specificity in a particular study but not for other relevant cutoffs
(Levis et al., 2017; Moriarty et al., 2015). Selective cutoff reporting
can lead to overestimation of diagnostic accuracy in primary studies
and in meta‐analyses that synthesize results from primary studies
with selectively reported results (Leeflang et al., 2008).
Only one previous study has investigated selective cutoff
reporting patterns in test accuracy studies (Levis et al., 2017). That
study obtained individual participant data (IPD) from 13 primary
studies included in a published meta‐analysis (Manea et al., 2012) of
the accuracy of the Patient Health Questionnaire‐9 (PHQ‐9)
depression screening tool. Results based on two sets of meta‐analysis
were compared. First, meta‐analyses were conducted where the
result at each cutoff was based only on those studies that published
results at that cutoff. Second, meta‐analyses were conducted based
on the IPD; the result at each cutoff was calculated from all studies
available regardless of what cutoff was originally published. Sensi-
tivity estimates differed substantially between published and IPD
datasets for cutoffs lower and higher than the standard cutoff of 10
(meaning cutoff ≥10) but were similar at the standard cutoff. This
was because most studies published results for the standard cutoff,
but authors tended to publish results from cutoffs lower or higher
than 10 depending on whether the PHQ‐9 was relatively poorly
sensitive but specific (lower cutoffs published) or highly sensitive but
poorly specific (higher cutoffs published) in their dataset.
A cutoff of 10 is used as the standard cutoff for screening for
major depression with the PHQ‐9 (Gilbody et al., 2007; Kroenke
et al., 2001; Kroenke & Spitzer, 2002; Spitzer et al., 1999; Wittkampf
et al., 2007) and maximizes combined sensitivity and specificity (Levis
et al., 2019), but standard cutoffs are less well‐defined for other
depression screening tools. Studies of the Edinburgh Postnatal
Depression Scale (EPDS), the most commonly used screening tool
among women in pregnancy and postpartum (Hewitt et al., 2009;
Howard et al., 2014), typically consider cutoffs between 10 and 13 as
standard, with 13 being most commonly used (Hewitt et al., 2009;
O'Connor et al., 2016). A recent IPD meta‐analysis (IPDMA) found
that cutoff 11 maximizes combined sensitivity and specificity (Levis
et al., 2020).
The degree to which there is an agreed upon standard cutoff for
a screening tool may influence selective cutoff reporting. Thus, this
study aimed to compare selective cutoff reporting in screening tools
with and without a well‐defined standard cutoff. We evaluated se-
lective cutoff reporting with a substantially larger set of PHQ‐9
studies than was used in the previous study (Levis et al., 2017) and
compared results to the EPDS, which does not have a well‐defined
standard cutoff. Specific objectives were to use IPDMA with the
PHQ‐9 and EPDS, separately, to (1) compare sensitivity and
specificity based on all cutoffs from all primary studies versus data
from only cutoffs for which accuracy estimates were published in the
primary studies; and (2) explore cutoff reporting patterns with
reference to the identified optimal cutoff in each primary study.
2 | METHODS
We analyzed data accrued for IPDMAs on PHQ‐9 and EPDS
diagnostic accuracy (PROSPERO CRD42014010673,
CRD42015024785), and protocols were published for each IPDMA
(Thombs et al., 2014, 2015). The protocol for the present study,
which was not part of the main IPDMA protocols, was published
separately (https://osf.io/vw3bz/). The protocol described only the
EPDS analysis, and we subsequently added the PHQ‐9 to be able to
compare screening tools with and without well‐defined standard
cutoffs. As this study involved only analysis of previously collected
de‐identified data and because all included studies were required to
have obtained ethics approval and informed consent, the Research
Ethics Committee of the Jewish General Hospital determined that
ethics approval was not required.
2.1 | Study eligibility
Datasets from articles in any language were eligible for the main
IPDMAs if (1) they used the PHQ‐9 or EPDS; (2) they included
diagnostic classification for current Major Depressive Disorder
(MDD) or Major Depressive Episode (MDE) using Diagnostic and
Statistical Manual of Mental Disorders (DSM) or International Clas-
sification of Diseases (ICD) criteria based on a validated diagnostic
interview; (3) the interview and PHQ‐9 or EPDS were administered
within 2 weeks of each other; (4) participants were ≥18 years and not
recruited from school‐based settings (PHQ‐9) or ≥18 years and
pregnant or within 12 months postpartum (EPDS); and (5) partici-
pants were not recruited from psychiatric settings or because they
had symptoms of depression, since screening is done to identify
previously unrecognized cases. Datasets where not all participants
were eligible were included if primary data allowed selection of
eligible participants.
Many primary studies in the main IPDMA databases that
contributed eligible datasets never published estimates of screening
accuracy. Thus, for the present study, we restricted analyses to pri-
mary studies with publications that included sensitivity and speci-
ficity estimates for at least one PHQ‐9 or EPDS cutoff for identifying
major depression. We excluded studies if the sample size from the
published primary study differed by >10% from the sample included
in our IPDMA datasets. Sample sizes from original primary studies
and the IPDMA databases differed in some cases because, for
instance, we excluded participants who were included in the original
studies if there were >2 weeks between their index test and refer-
ence standard administrations or if they were <18 years old. We also
excluded primary studies with publications that reported accuracy
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results only for diagnostic classifications broader than major
depression (e.g., “any depressive disorder”) if the number of cases in
the published article and IPDMA datasets differed by >10%.
2.2 | Search strategy and study selection
A medical librarian searched Medline, Medline In‐Process & Other
Non‐Indexed Citations and PsycINFO via OvidSP, and Web of Sci-
ence via ISI Web of Knowledge from January 1, 2000 to February 7,
2015 (Method S1a) for the PHQ‐9 and from inception to June 10,
2016 (Method S1b) for the EPDS, using peer‐reviewed search stra-
tegies (McGowan et al., 2016). We also reviewed reference lists of
relevant reviews and queried contributing authors about non‐
published studies. Search results were uploaded into RefWorks
(RefWorks‐COS) for de‐duplication and then into DistillerSR (Evi-
dence Partners).
Two investigators independently reviewed titles and abstracts. If
either deemed a study potentially eligible, full‐text review was done
by two investigators, independently, with disagreements resolved by
consensus, consulting a third investigator when necessary. Trans-
lators were consulted for languages other than those for which team
members were fluent.
2.3 | Data contribution, extraction, and synthesis
Authors of eligible datasets were emailed invitations to contribute
de‐identified primary data at least three times, as necessary. If there
was no response, we emailed co‐authors and attempted phone con-
tact. For each study, we compared published results with results from
raw datasets and resolved any discrepancies in consultation with
primary study investigators. For defining major depression, we
considered MDD or MDE based on DSM or ICD. If more than one
was reported, we prioritized MDE over MDD and DSM over ICD. For
studies with multiple time points, we included data from only the
time point with the most participants. To facilitate comparison be-
tween published results and IPDMA results, we applied sampling
weights in the IPDMA only when accuracy results reported in the
original published study were calculated using weights.
We determined whether included primary studies cited the
Standards for Reporting of Diagnostic Test Accuracy (STARD)
guideline in the publication or not (Bossuyt et al., 2003).
2.4 | Statistical analyses
We replicated the statistical analyses used in the previous study of
selective cutoff reporting with the PHQ‐9 (Levis et al., 2017). We
estimated sensitivity and specificity from cutoffs up to 5 points below
and above cutoffs used as standard (PHQ‐9 cutoff 10, range 5–15;
EPDS cutoffs 10–13, range 5–18). We compared meta‐analyses re-
sults from data using only cutoffs for which accuracy estimates were
published in the primary studies (the published dataset) and using data
from all cutoffs from all studies (the full dataset).
For both sets of meta‐analyses, for each cutoff, bivariate
random‐effects models were estimated via Gauss‐Hermite quadra-
ture (Riley et al., 2008). This approach models sensitivity and speci-
ficity simultaneously, accounting for the inherent correlation
between them and the precision of estimates within studies.
2.4.1 | Differences in sensitivity and specificity
estimates using published versus full datasets
In order to examine differences in results produced by meta‐analyses
based on published and full datasets, we constructed separate pooled
receiver operator characteristic (ROC) curves. In addition, 95%
confidence intervals for the differences in sensitivity and specificity
at each cutoff were constructed via bootstrap (Van der Leeden
et al., 1997, 2008) resampling at the study and subject level with
1000 iterations for each cutoff. We calculated the median absolute
difference in estimated sensitivity and specificity across evaluated
cutoffs.
2.4.2 | Reporting patterns
We assessed whether primary studies tended to preferentially report
low or high cutoffs depending on the study's sample‐specific optimal
cutoff. For each primary study, we identified the optimal cutoff that
the authors explicitly described as optimal or using a similar term. If
the authors did not identify an optimal cutoff, we used the cutoff that
maximized Youden's J (sensitivity + specificity−1) (Youden, 1950).
For each study, we plotted the optimal cutoff, along with all other
cutoffs for which results were published. We noted whether the re-
ported cutoffs tended to be low or high compared to the standard
cutoff (PHQ‐9 10) or set of commonly used cutoffs (EPDS 10–13).
For studies with optimal cutoffs below and above the standard or
commonly used cutoffs, separately, we calculated the mean of the
cutoffs reported.
3 | RESULTS
3.1 | Identification of eligible studies
3.1.1 | Patient Health Questionnaire‐9
Of 58 studies included in the main IPDMA (Levis et al., 2019), 28
were excluded from the present study because they did not publish
diagnostic accuracy results for any PHQ‐9 cutoffs or because the
number of participants or major depression cases in the IPD dataset
differed by >10% from the published studies or could not be deter-
mined (Figure S1a; Tables S1a and S2a). The final dataset included 30
studies (N total: 11,773; N major depression: 1587 [13%]; Table S3a)
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that compared the PHQ‐9 with a validated diagnostic interview (Mini
Neurospsychiatric Diagnostic Interview, Structured Clinical Inter-
view for DSM Disorders, Composite International Diagnostic Inter-
view, Clinical Interview Schedule Revised, Schedules for Clinical
Assessment in Neuropsychiatry or Computerized Diagnostic Inter-
view Schedule). Of the 30 included studies, 7 reported only a single
cutoff and 23 reported more than one cutoff. Of the 23 with multiple
cutoffs reported, 18 identified an optimal cutoff in the published
study; of those, 16 (89%) were described as based on Youden's J (N:
8) or equivalent to Youden's calculated from published cutoffs but
did not have an explanation (N: 8). Among the 30 studies, only two
cited the STARD reporting guideline (Arroll et al., 2010; Sherina
et al., 2012).
3.1.2 | Edinburgh Postnatal Depression Scale
Of 49 studies in the original IPDMA dataset (Levis et al., 2020), 30
studies were not eligible and thus excluded from the present study
(Figure S1b; Tables S1b and S2b). Thus, 19 unique studies (N total:
3637, N major depression: 531 [15%]) were included (Table S3b),
which compared the EPDS with a validated diagnostic interview
including Mini Neuropsychiatric Diagnostic Interview, Structured
Clinical Interview for DSM Disorders, Clinical Interview Schedule and
Diagnostic Interview of Genetic Studies. Of the 14 studies that re-
ported more than one cutoff, 13 identified an optimal cutoff; of those
10 (77%) were based on Youden's J (N: 2) or did not have an
explanation but matched what would have been obtained using
Youden's J calculated from published cutoffs (N: 8). None of the
studies cited STARD.
3.2 | Differences in sensitivity and specificity
estimates based on published versus full datasets
Table 1 shows sensitivity and specificity for the PHQ‐9 and EPDS at
each cutoff for the published and full datasets with the ROC plots in
Figures 1 and 2.
3.2.1 | Patient Health Questionnaire‐9
The difference between estimated sensitivity (published—full dataset)
ranged from −0.09 to 0.10 (median: 0.06; Table 2). For cutoffs
below 10, estimated sensitivity was lower for the published dataset
(−0.02 to −0.09; median: −0.06) with 95% CIs including zero but
inclining more towards negative, whereas estimated specificity was
higher (0.01 to 0.14; median: 0.03) with 95% CIs including zero. For
the standard cutoff 10, the differences in sensitivity and specificity
were −0.01 (95% CI: −0.05, 0.01), and 0.01 (95% CI: 0.00, 0.04),
respectively. For cutoffs above 10, estimated sensitivity was higher
for the published dataset (0.00 to 0.10; median: 0.07) with 95% CIs
including zero but inclining more towards positive, and estimated
specificity was similar (0.00 to 0.02; median: 0.01) with 95% CIs
including zero.
3.2.2 | Edinburgh Postnatal Depression Scale
The difference between estimated sensitivity ranged from −0.02 to
0.20 (median: 0.03) with all 95% CIs including zero (Table 2). For
cutoffs below 10, estimated sensitivity (−0.02 to 0.01; median: 0.00),
and estimated specificity (‐0.01 to 0.02; median: 0.01) were similar
for the published and full datasets. For cutoffs of 10 to 13, estimated
sensitivity differed by 0.02 to 0.03 (median: 0.03), and estimated
specificity differed by ‐0.02 to 0.00 (median: ‐0.02). For cutoffs above
13, estimated sensitivity was higher for the published dataset
(0.08 to 0.20; median: 0.14), and estimated specificity was similar or
lower (‐0.08 to 0.00; median: 0.00).
3.3 | Reporting patterns
3.3.1 | Patient Health Questionnaire‐9
Figure 3 shows the pattern of reporting with respect to optimal
cutoffs for included PHQ‐9 studies; 9 studies had optimal cutoffs
below 10, 14 equal to 10, 6 greater than 10 and 1 study had optimal
cutoffs of both 10 and 12. Studies for which the PHQ‐9 was poorly
sensitive at the cutoff 10 (sensitivity: 0.27–0.74) (Arroll et al., 2010;
Inagaki et al., 2013; Lambert et al., 2015; Lotrakul et al., 2008; Pence
et al., 2012; Thombs et al., 2008; Stafford et al., 2007; Sung
et al., 2013; Turner et al., 2012) had optimal cutoffs that were below
10. These studies tended to report more cutoffs below 10 than above
10 (mean of reported cutoffs: 8.8). Studies for which the PHQ‐9 was
highly sensitive at cutoff 10 (sensitivity: 0.85–1.00) (Bombardier
et al., 2012; Delgadillo et al., 2011; Fann et al., 2005; Khamseh
et al., 2011; Lowe et al., 2004; Twist et al., 2013) had optimal cutoffs
that were greater than 10. These studies tended to report more
cutoffs above 10 than below 10 (mean of reported cutoffs: 11.8).
3.3.2 | Edinburgh Postnatal Depression Scale
Figure 4 shows the pattern of reporting cutoffs for the EPDS; 5
studies had optimal cutoffs below 10, 13 between 10 and 13, and 1
greater than 13. Studies for which the EPDS was poorly sensitive at
cutoff 10 (sensitivity: 0.43–0.73) (Bakare et al., 2014; Chaudron
et al., 2010; Radoš et al., 2013; Thiagayson et al., 2013; Toreki
et al., 2013) had optimal cutoffs that were less than 10 (mean of
reported cutoffs: 9.9). Studies for which EPDS was highly sensitive at
cutoff 10 (sensitivity: 0.82–1.00) (Alvarado et al., 2015; Beck & Ga-
ble, 2001; Bunevicius et al., 2009; Couto et al., 2015; Garcia‐Esteve
et al., 2003; Khalifa et al., 2015; Phillips et al., 2009; Rochat
et al., 2013; Su et al., 2007; Tandon et al., 2012; Toreki et al., 2014;
Vega‐Dienstmaier et al., 2002) had optimal cutoffs greater than 10.
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These studies tended to report more cutoffs above 10 than below 10
(mean of reported cutoffs: 11.8). All of these studies had optimal
cutoffs between 10 and 13 with one exception, a study reported
accuracy only for cutoff 13 even though sensitivity was low at this
cutoff (sensitivity: 0.35) (Pawlby et al., 2008).
4 | DISCUSSION
We compared bias in accuracy and selective cutoff reporting be-
tween the PHQ‐9, which has a clearly defined standard cutoff and
the EPDS, which does not have a clearly defined standard cutoff,
TAB L E 1 Comparison of accuracy results from IPDMA of PHQ‐9 and EPDS with the published dataset only versus the full dataset
PHQ‐9
Published dataset
Full dataset 30 studies; N = 11 773;







cases Sensitivity 95% CI Specificity 95% CI Sensitivity 95% CI Specificity 95% CI
5 5 1663 367 0.91 0.86, 0.94 0.68 0.55, 0.79 0.97 0.94, 0.98 0.54 0.48, 0.60
6 6 2193 377 0.87 0.77, 0.93 0.72 0.61, 0.82 0.96 0.92, 0.97 0.62 0.56, 0.68
7 6 2050 438 0.87 0.75, 0.93 0.72 0.60, 0.81 0.94 0.90, 0.97 0.69 0.63, 0.74
8 12 5798 720 0.87 0.78, 0.92 0.77 0.70, 0.82 0.92 0.87, 0.95 0.75 0.70, 0.79
9 14 5283 766 0.85 0.76, 0.91 0.81 0.75, 0.85 0.87 0.81, 0.91 0.80 0.76, 0.84
10 26 10 593 1378 0.82 0.74, 0.88 0.86 0.83, 0.89 0.83 0.76, 0.88 0.85 0.81, 0.88
11 15 5292 767 0.83 0.72, 0.91 0.88 0.83, 0.92 0.76 0.69, 0.82 0.88 0.85, 0.91
12 16 6188 832 0.73 0.63, 0.81 0.91 0.87, 0.94 0.69 0.62, 0.75 0.91 0.88, 0.93
13 9 2104 455 0.70 0.59, 0.79 0.95 0.87, 0.98 0.60 0.54, 0.67 0.93 0.91, 0.95
14 5 1231 277 0.63 0.47, 0.76 0.96 0.89, 0.99 0.54 0.47, 0.61 0.95 0.93, 0.96
15 6 3546 374 0.47 0.37, 0.59 0.97 0.97, 0.98 0.47 0.40, 0.54 0.96 0.95, 0.97
EPDS
Published dataset
Full dataset 19 studies; N = 3637;







MD cases Sensitivity 95% CI Specificity 95% CI Sensitivity 95% CI Specificity 95% CI
5 4 830 52 0.98 0.84, 1.00 0.38 0.18, 0.62 0.98 0.95, 0.99 0.36 0.29, 0.43
6 4 830 52 0.98 0.86, 1.00 0.46 0.23, 0.70 0.97 0.93, 0.98 0.45 0.37, 0.53
7 7 1413 122 0.93 0.84, 0.97 0.56 0.41, 0.70 0.94 0.89, 0.97 0.55 0.47, 0.62
8 9 1920 194 0.92 0.80, 0.97 0.62 0.47, 0.74 0.91 0.85, 0.94 0.63 0.55, 0.71
9 13 2807 342 0.85 0.78, 0.91 0.72 0.63, 0.80 0.87 0.81, 0.91 0.71 0.63, 0.78
10 11 2215 210 0.84 0.73, 0.91 0.78 0.68, 0.85 0.82 0.76, 0.87 0.79 0.72, 0.84
11 13 2462 277 0.83 0.72, 0.90 0.83 0.76, 0.89 0.80 0.72, 0.86 0.85 0.79, 0.90
12 12 2373 252 0.75 0.60, 0.86 0.87 0.80, 0.92 0.72 0.63, 0.80 0.89 0.84, 0.92
13 17 3032 447 0.68 0.59, 0.76 0.93 0.89, 0.96 0.65 0.56, 0.74 0.93 0.89, 0.95
14 9 1950 184 0.66 0.54, 0.76 0.95 0.89, 0.98 0.58 0.49, 0.67 0.95 0.92, 0.97
15 6 1286 131 0.65 0.55, 0.73 0.96 0.90, 0.98 0.50 0.43, 0.58 0.96 0.94, 0.98
16 3 682 65 0.61 0.47, 0.73 0.98 0.78, 1.00 0.41 0.35, 0.49 0.98 0.96, 0.99
17a 1 306 19 0.47 0.25, 0.71 0.91 0.87, 0.94 0.33 0.27, 0.41 0.99 0.97, 0.99
18a 1 306 19 0.37 0.17, 0.61 0.95 0.92, 0.97 0.26 0.21, 0.33 0.99 0.98, 1.00
Abbreviations: CI, Confidence Interval; EPDS, Edinburgh Postnatal Depression Scale; IPDMA, Individual Participant Data Meta‐analysis; MD, Major
Depression.
aFor these cutoffs, one sample proportion test with continuity correction was used to estimate sensitivity and specificity and confidence intervals.
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using IPD. Selective cutoff reporting was more pronounced for the
PHQ‐9, and bias in estimated accuracy of published cutoffs compared
to all cutoffs was similarly greater for the PHQ‐9.
For the PHQ‐9, compared to meta‐analysis of the full dataset,
which included results for all relevant cutoffs for all included studies,
specificity estimates using the published dataset, which included re-
sults from published cutoffs only, were similar; however, sensitivity
was underestimated in the published dataset for cutoffs below 10,
similar for the standard cutoff 10, and overestimated for cutoffs
above 10. The cutoff reporting pattern in primary studies explains
this pattern of under and overestimation of sensitivity. Studies in
which the PHQ‐9 was poorly sensitive but more specific identified
cutoffs below 10 as optimal and reported more cutoffs below 10,
whereas studies in which the PHQ‐9 was highly sensitive but less
specific identified cutoff above 10 as optimal and reported more
cutoffs above 10.
For the EPDS, compared to the full dataset, specificity estimates
using the published dataset was similar across all cutoffs; however,
sensitivity estimates were similar for cutoffs below 10 and for the
most commonly reported cutoffs 10–13, but overestimated for
cutoffs above 13. Unlike the PHQ‐9, only primary studies in which
the EPDS was highly sensitive at cutoff 10 reported more cutoffs
above 10. Studies with poor sensitivity that reported optimal cutoffs
below 10 reported results from cutoffs above 10 more often than
comparable studies with the PHQ‐9. This may be because the PHQ‐9
has a single standard cutoff of 10, whereas for the EPDS it is an
expectation that results for commonly used cutoffs of 10–13 are
reported.
The 2001 PHQ‐9 validation study, which included only 41 major
depression cases, identified 10 as the standard cutoff (Kroenke
et al., 2001; Spitzer et al., 1999). Similarly, the 1987 EPDS validation
study, which included only 24 definite or probable major depression
cases, suggested that cutoffs of 10 or 13 could be used (Cox
et al., 1987). Consequently, most PHQ‐9 studies report accuracy for
cutoff 10, but selectively reported accuracy for cutoffs other than 10
depending upon the sensitivity at cutoff 10 (Levis et al., 2017;
Moriarty et al., 2015). In the absence of a single standard cutoff,
EPDS studies often report a range of cutoffs from 10 to 13 (Hewitt
et al., 2009; O'Connor et al., 2016).
Only one previous study, an IPDMA with 13 studies (4589 par-
ticipants, 1037 major depression cases), has examined selective
cutoff reporting in screening instruments (for the PHQ‐9) (Levis
et al., 2017). We replicated the analysis with much larger sample (30
studies; 11,773 participants; 1587 cases) and found that although the
reporting patterns were similar, the magnitude of bias was lower in
the present study. In the previous study, when the cutoff increased
from 9 to 10 and 10 to 11, the sensitivity also increased markedly, an
impossible finding if all data are analyzed. In the present study, the
sensitivity increased when cutoff increased from 10 to 11, but the
increment was minimal. The reduction in the magnitude of bias due
to selective reporting compared to the previous study may be due to
improved reporting practices over time. This could, however, also be
a result of differences in inclusion criteria in the two studies. Of the
13 primary studies included in the previous study, six were excluded
from the present study for one of the following reasons: selecting
sample for existing distress, mental health diagnosis or from psy-
chiatric settings; having >10% difference in sample size or MDD
cases between IPD and published dataset; or administering the PHQ‐
9 and diagnostic interview more than 2 weeks apart.
Primary studies are often carried out to identify optimal cutoffs
and explore accuracy of a screening tool in a specific population;
regardless, the full range of cutoffs should be reported. According to
STARD reporting guidelines, diagnostic accuracy estimates and pre-
cision, as well as the cross tabulation of the index test and the
reference standard should be reported (Bossuyt et al., 2015). The
guideline should also recommend reporting accuracy estimates for all
F I GUR E 1 Receiver operating characteristic (ROC) curves plot
for the diagnostic accuracy of Patient Health Questionnaire‐9
(PHQ‐9). The points in the ROC curves indicate each of the PHQ‐9
cutoffs between 5 (right) and 15 (left)
F I GUR E 2 Receiver operating characteristic (ROC) curves plot
for the diagnostic accuracy of Edinburgh Postnatal Depression
Scale (EPDS). The points in the ROC curves indicate each of the
EPDS cutoffs between 5 (right) and 18 (left)
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TAB L E 2 Differences in estimated sensitivity and specificity using the published dataset only versus the full dataset for PHQ‐9 and EPDS
PHQ‐9
% of participants included in published
results for each cutoff
Differences in estimates using published dataset versus full
dataset (published ‐ full)
Cutoff % participants % MD cases
Sensitivity Specificity
Estimated difference Bootstrap 95% CI Estimated difference
Bootstrap
95% CI
5 14 23 −0.06 −0.13, 0.00 0.14 0.02, 0.26
6 19 24 −0.09 −0.18, −0.01 0.10 0.00, 0.20
7 17 28 −0.07 −0.20, 0.00 0.03 −0.09, 0.15
8 49 45 −0.05 −0.14, 0.02 0.02 −0.03, 0.08
9 45 48 −0.02 −0.11, 0.05 0.01 −0.04, 0.05
10 90 87 −0.01 −0.05, 0.01 0.01 0.00, 0.04
11 45 48 0.07 0.00, 0.13 0.00 −0.03, 0.03
12 53 52 0.04 −0.03, 0.09 0.00 −0.02, 0.03
13 18 29 0.10 −0.02, 0.20 0.02 −0.04, 0.05
14 10 17 0.09 −0.07, 0.23 0.01 −0.04, 0.04
15 30 24 0.00 −0.12, 0.13 0.01 0.00, 0.03
EPDS
% of participants included in published
results for each cutoff
Differences in estimates using published dataset versus full dataset
(published—full)
Cutoff % participants % MD cases
Sensitivity Specificity
Estimate difference Bootstrap 95% CI Estimate difference
Bootstrap
95% CI
5 23 10 0.00 −0.06, 0.04 0.02 −0.16, 0.21
6 23 10 0.01 −0.04, 0.05 0.01 −0.19, 0.21
7 39 23 −0.01 −0.10, 0.07 0.01 −0.12, 0.15
8 53 37 0.01 −0.09, 0.08 −0.01 −0.13, 0.10
9 77 64 −0.02 −0.08, 0.06 0.01 −0.06, 0.08
10 61 40 0.02 −0.11, 0.10 −0.01 −0.09, 0.06
11 68 52 0.03 −0.06, 0.11 −0.02 −0.08, 0.03
12 65 47 0.03 −0.14, 0.15 −0.02 −0.09, 0.03
13 83 84 0.03 −0.03, 0.10 0.00 −0.02, 0.01
14 54 35 0.08 −0.11, 0.21 0.00 −0.06, 0.03
15 35 25 0.15 0.00, 0.32 0.00 −0.08, 0.03
16 19 12 0.20 −0.03, 0.39 0.00 −0.08, 0.03
17 8 4 0.14 −0.09, 0.37 −0.08 −0.11, −0.04
18 8 4 0.11 −0.12, 0.34 −0.04 −0.07, −0.01
Note: For PHQ‐9, 15 iterations (1.5%) that did not produce difference estimates were removed prior to determining the bootstrap CI.
For EPDS, 284 iterations (28.4%) for cutoffs 5‐6, 32 iterations (3.2%) for cutoffs 7‐15 and 275 iterations (27.5%) for cutoff 16 that did not produce
difference estimates were removed prior to determining bootstrap CIs. Only 1 study published EPDS cutoffs 17 and 18, so only participant level
resampling was done for published dataset.
Abbreviations: CI, Confidence Interval, EPDS: Edinburgh Postnatal Depression Scale, PHQ‐9, Patient Health Questionnaire‐9.
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relevant cutoffs for ordinal index tests. Citation of the STARD
guideline, however, was not common; only 2 of 49 PHQ‐9 and EPDS
studies (Arroll et al., 2010; Sherina et al., 2012) cited it. When data
are missing from some cutoffs in primary studies, conventional meta‐
analyses based on published cutoffs only may result in biased accu-
racy estimates. Accuracy estimates can be corrected in meta‐
analyses using modelling techniques (Benedetti et al., 2020) or by
doing IPDMA, which has some advantages, but is highly resource
intensive (Cochrane methods: IPD meta‐analysis, 2020; Ioannidis
et al., 2002; Riley et al., 2010; Stewart & Tierney, 2002).
The major strength of this study is that we compared two
depression screening instruments with different characteristics using
IPDMA. We explored how the presence of a clearly defined standard
cutoff versus the absence of such a standard may be associated with
bias in accuracy. A potential limitation is that we calculated the
optimal cutoff based on Youden's J for the studies not specifying an
optimal cutoff. Those studies may not have considered the cutoff that
maximized Youden's J as optimal. However, Youden's J appears to be
the most typical method of identifying optimal cutoff thresholds for
depression screening measures. In the present study, 16 of 18 (89%)
F I GUR E 3 Pattern of cutoff reporting for PHQ‐9 studies. Cells shaded in gray represent cutoff points for which diagnostic accuracy
results are reported in the primary studies. “O” represents the optimal cutoff for PHQ‐9 explicitly stated in the studies except for Inagaki
et al. (2013), Pence et al. (2012), Arroll (2010), Cholera (2014), Amoozegar (2017), which did not identify an optimal cutoff. For those,
Youden's J optimal was calculated from published accuracies. For Gjerdingen (2009) and Vöhringer (2013), only one cutoff was reported
without stating whether it was optimal or not. van Steenbergen‐Weijenburg 2010 reported 10 and 12 as optimal cutoffs. Studies that reported
accuracies for cutoffs beyond presented in the table: Inagaki et al. (2013) reported the accuracy for cutoffs 4–13, Thombs (2008) reported the
accuracy for cutoffs 1–10, Lambert et al. (2015) reported the accuracy for cutoffs 5, 9, 10, 15, 20, Hyphantis (2011) reported the accuracy for
cutoffs 4–16, Osorio (2009) reported the accuracy for cutoffs 10–21. All the reported cutoffs were included while calculating the mean of
reported cutoffs though they are not shown in the figure
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PHQ‐9 studies and 10 of 13 (77%) EPDS studies with multiple re-
ported cutoffs that identified an optimal cutoff used Youden's J or
identified an optimal cutoff that was equivalent to the Youden's
J optimal cutoff. Another possible limitation is that we examined
primary studies regardless of the reference standard that was used in
each study. We have previously shown that different types of diag-
nostic interviews perform differently (Wu et al., 2021). We do not
believe, however, that the reference standard used would have likely
influenced decisions about which cutoffs to report in primary studies.
When studies appeared to report cutoffs selectively depending
upon the sensitivity at the standard cutoff, synthesis of accuracy
results from published cutoffs led to underestimation of sensitivity
below the standard cutoff and overestimation of sensitivity above
the standard cutoff. This phenomenon appears to be diluted for EPDS
when the standard cutoff is not clearly defined and there is a range of
commonly used and reported cutoffs, because the primary studies
tend to report a range of cutoffs around the true optimal cutoff. To
reduce bias in evidence syntheses, researchers conducting primary
studies should report accuracy estimates or a contingency table for
all relevant cutoffs, or make their primary data available. Researchers
who conduct meta‐analyses should use modelling approaches to
overcome possible biases from selective cutoff reporting or should
use an IPDMA approach.
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